Your Gift Drives Advocacy

Government Shutdown: What Patients with Brain Tumors & Care Partners Need to Know Update (9/30/23): Congress passed a short-term Continuing Resolution (CR), which will keep the government operating at Fiscal Year 2023 funding levels until mid-November buying more time to come to an agreement on a full FY 2024 budget. While a CR is preferable to a shutdown, the brain tumor community needs increases to research funding as […] September 26, 2023

Five Years of Glioblastoma Awareness Day: Five Advancements & Five Challenges The establishment of a national Glioblastoma (GBM) Awareness Day has, in many ways, driven significant progress for the GBM and entire brain tumor community. This year as we recognize the fifth annual Glioblastoma Awareness Day, it’s important that we take stock of these accomplishments, which have only been achievable through the dedicated advocacy and efforts […] July 20, 2023

National Brain Tumor Society Participates in White House Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG), Makes Moonshot Commitment Today, the National Brain Tumor Society (NBTS) will participate in the first White House Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) during national Brain Tumor Awareness Month. In joining the forum, NBTS will affirm its pledge to defeat brain tumors and improve the lives of patients with brain […] May 25, 2023

National Brain Tumor Society Statement on 5th Annual Congressional Glioblastoma Awareness Day Resolution In anticipation of the 5th anniversary of Glioblastoma Awareness Day, the National Brain Tumor Society has once again worked with a bipartisan group of U.S. Senators and Representatives to introduce a congressional resolution designating Wednesday, July 19, as a day to raise public awareness for this highly aggressive and deadly form of brain cancer. In […] May 18, 2023

Neuro-oncologist Advocates for Brain Tumor Community at Head to the Hill After three years of attending Head to the Hill virtually due to the pandemic, neuro-oncologist Dr. Nicholas Blondin is counting down the days to the event’s return in person to Capitol Hill this May 8-9. As a neuro-oncologist and the lead principal investigator of GBM AGILE at Yale Cancer Center and Smilow Cancer Hospital, Dr. […] March 27, 2023